Gene · 3925
Papers4,446
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,446
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chimeric Antigen Receptor T Cell Therapy Targeting Epithelial Cell Adhesion Molecule in Gastric Cancer: Mechanisms of Tumor Resistance. | Cancers (Basel) | 2023 | 38067255 | PubTator, text mining | PubMed |
| The tubulin database: Linking mutations, modifications, ligands and local interactions. | PLoS One | 2023 | 38064432 | PubTator, text mining | PubMed |
| Insights on epithelial cells at the single-cell level in hepatocellular carcinoma prognosis and response to chemotherapy. | Front Pharmacol | 2023 | 38044951 | PubTator, text mining | PubMed |
| Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primates. | Nat Commun | 2023 | 38042809 | PubTator, text mining | PubMed |
| Association Between High Expression of Phosphorylated-STMN1 and Mesenchymal Marker Expression and Cancer Stemness in Breast Cancer. | Anticancer Res | 2023 | 38030185 | PubTator, text mining | PubMed |
| Neurogenesis in primates versus rodents and the value of non-human primate models. | Natl Sci Rev | 2023 | 38025664 | PubTator, text mining | PubMed |
| A prognostic model for tumor recurrence and progression after meningioma surgery: preselection for further molecular work-up. | Front Oncol | 2023 | 38023177 | PubTator, text mining | PubMed |
| The crosstalk among the physical tumor microenvironment and the effects of glucose deprivation on tumors in the past decade. | Front Cell Dev Biol | 2023 | 38020920 | PubTator, text mining | PubMed |
| High-dimensional single-cell proteomics analysis of esophageal squamous cell carcinoma reveals dynamic alterations of the tumor immune microenvironment after neoadjuvant therapy. | J Immunother Cancer | 2023 | 38016720 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| GITR and TIGIT immunotherapy provokes divergent multicellular responses in the tumor microenvironment of gastrointestinal cancers. | Genome Med | 2023 | 38008725 | PubTator, text mining | PubMed |
| LEO1 Is Required for Efficient Entry into Quiescence, Control of H3K9 Methylation and Gene Expression in Human Fibroblasts. | Biomolecules | 2023 | 38002344 | PubTator, text mining | PubMed |
| Elevated stress response marks deeply quiescent reserve cells of gastric chief cells. | Commun Biol | 2023 | 37985874 | PubTator, text mining | PubMed |
| Electroconvulsive therapy is associated with increased immunoreactivity of neuroplasticity markers in the hippocampus of depressed patients. | Transl Psychiatry | 2023 | 37981649 | PubTator, text mining | PubMed |
| Prediction of lymph node metastasis in early esophageal cancer. | World J Gastrointest Surg | 2023 | 37969711 | PubTator, text mining | PubMed |
| Inactivation of the tumor suppressor gene Apc synergizes with H. pylori to induce DNA damage in murine gastric stem and progenitor cells. | Sci Adv | 2023 | 37967175 | PubTator, text mining | PubMed |
| LASS2 enhances p53 protein stability and nuclear import to suppress liver cancer progression through interaction with MDM2/MDMX. | Cell Death Discov | 2023 | 37963859 | PubTator, text mining | PubMed |
| A pathway activity-based proteomic classifier stratifies prostate tumors into two subtypes. | Clin Proteomics | 2023 | 37950160 | PubTator, text mining | PubMed |
| Essential procedures of single-cell RNA sequencing in multiple myeloma and its translational value. | Blood Sci | 2023 | 37941914 | PubTator, text mining | PubMed |
| The RioK1 network determines p53 activity at multiple levels. | Cell Death Discov | 2023 | 37935656 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3925/papers?page=14